NCT00934076 2015-05-08Tarceva and AT-101 for Patients With Advanced Non-Small Cell Lung CancerUniversity of Alabama at BirminghamPhase 1 Withdrawn
NCT00544960 2010-08-27A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung CancerAscenta TherapeuticsPhase 2 Completed106 enrolled